Cardiovascular Drugs — MCQs
On this page
Which of the following is non-selective 3rd generation Beta blocker ?
Which class of antihypertensive drugs is known to cause erectile dysfunction?
Which of the following medications is not typically used for the treatment of erectile dysfunction?
Drug of choice for open angle glaucoma:
Which prostaglandin inhibitor is used in the treatment of patent ductus arteriosus (PDA)?
Which drug is used to keep the patent ductus arteriosus (PDA) open?
Drug of choice for familial hypercholesterolemia?
What are the primary mechanisms behind cardiac toxicity associated with Tricyclic antidepressants?
Nesiritide causes vasodilation through?
Which of the following is NOT a side effect of digitalis?
Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs
Question 1061: Which of the following is non-selective 3rd generation Beta blocker ?
- A. Betaxolol
- B. Celiprolol
- C. Nebivolol
- D. Carvedilol (Correct Answer)
Explanation: ***Carvedilol*** - **Carvedilol** is a **non-selective beta-adrenergic antagonist** (blocks both β1 and β2 receptors) with **additional α1-adrenergic blocking activity**, making it a true **3rd generation beta-blocker**. - The α1-blockade provides **vasodilatory properties**, reducing peripheral vascular resistance and improving hemodynamics. - It has favorable effects on lipid metabolism and insulin sensitivity, making it particularly useful in heart failure and hypertension. - Its non-selective beta-blockade combined with vasodilation distinguishes it from selective 3rd generation agents. *Betaxolol* - **Betaxolol** is a **selective β1-adrenergic antagonist** without vasodilatory properties. - Classified as a **2nd generation beta-blocker** due to its cardioselectivity. - Primarily used in glaucoma and hypertension but lacks the non-selective profile and additional mechanisms of 3rd generation agents. *Celiprolol* - **Celiprolol** is a **β1-selective antagonist** with **β2-agonistic effects** providing vasodilation. - While classified as 3rd generation due to vasodilatory properties, it is **selective for β1**, not non-selective. - Its β2-agonism causes peripheral vasodilation but maintains β1-selectivity. *Nebivolol* - **Nebivolol** is a highly **selective β1-adrenergic antagonist** with **vasodilatory effects via nitric oxide (NO) release**. - Classified as 3rd generation due to NO-mediated vasodilation, but it is **β1-selective**, not non-selective. - The combination of high β1-selectivity and endothelial-mediated vasodilation makes it unique among 3rd generation agents.
Question 1062: Which class of antihypertensive drugs is known to cause erectile dysfunction?
- A. Calcium channel blocker
- B. ACE inhibitors
- C. AT1 receptor antagonists
- D. Beta-blockers (Correct Answer)
Explanation: ***Beta-blockers*** - **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction** - Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation - **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol) - Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction *Calcium channel blockers* - Generally have **neutral or minimal effect** on erectile function - May even improve ED in some patients due to **vasodilatory properties** - Side effects include peripheral edema and headache, but not sexual dysfunction *ACE inhibitors* - Associated with **lower risk of erectile dysfunction** compared to other antihypertensives - May have neutral or even protective effects on sexual function - Preferred choice for hypertensive patients with existing sexual dysfunction concerns - Common side effects: dry cough and angioedema (not related to sexual function) *AT1 receptor antagonists* - **ARBs have neutral to potentially beneficial effects** on sexual function - Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications - Some studies suggest they may improve erectile function in hypertensive patients
Question 1063: Which of the following medications is not typically used for the treatment of erectile dysfunction?
- A. Beta blockers (Correct Answer)
- B. Papaverine
- C. Sildenafil
- D. PG-E
Explanation: ***Beta blockers*** - **Beta blockers** are primarily used to treat conditions like **hypertension** and **heart disease**. - While they can cause ED as a side effect, they are **not used for its treatment**. *Sildenafil* - **Sildenafil** is a **PDE5 inhibitor** that works by increasing **blood flow to the penis**, facilitating an erection. - It is a **first-line oral medication** widely prescribed for erectile dysfunction. *PG-E* - **PG-E** refers to **Prostaglandin E1** (alprostadil), which can be administered via **intracavernosal injection** or **urethral suppository**. - It directly causes **vasodilation** in the penis, leading to an erection, and is used when oral medications are ineffective or contraindicated. *Papaverine* - **Papaverine** is a **non-specific vasodilator** that can be used as an **intracavernosal injection** for ED. - It works by relaxing **smooth muscle** in the penile arteries, increasing blood flow and inducing an erection, often used in combination with phentolamine.
Question 1064: Drug of choice for open angle glaucoma:
- A. Acetazolamide
- B. Latanoprost (Correct Answer)
- C. Brimonidine
- D. Timolol
Explanation: ***Latanoprost*** - **Prostaglandin F2α analogs** like latanoprost are generally considered **first-line therapy** for open-angle glaucoma due to their efficacy and once-daily dosing. - They work by **increasing uveoscleral outflow** of aqueous humor, thereby lowering intraocular pressure (IOP). *Acetazolamide* - **Acetazolamide** is a **carbonic anhydrase inhibitor** that reduces aqueous humor production. - It is typically used for **acute angle-closure glaucoma** or when initial treatments fail, often due to systemic side effects with long-term use. *Timolol* - **Timolol** is a **non-selective beta-blocker** that reduces aqueous humor production. - While effective, it is often a second-line agent or used in combination due to potential systemic side effects like **bronchospasm** and **bradycardia**. *Brimonidine* - **Brimonidine** is an **alpha-2 adrenergic agonist** that reduces aqueous humor production and increases uveoscleral outflow. - It is typically used as a second-line agent or in combination therapy due to potential side effects like **ocular pruritus** and **allergic conjunctivitis**.
Question 1065: Which prostaglandin inhibitor is used in the treatment of patent ductus arteriosus (PDA)?
- A. PGE-2
- B. Misoprostol
- C. Indomethacin (Correct Answer)
- D. Dinoprostone
Explanation: ***Indomethacin*** - **Indomethacin** is a non-steroidal anti-inflammatory drug (**NSAID**) that inhibits **prostaglandin synthesis**, particularly **prostaglandin E2 (PGE2)**. - **PGE2** helps keep the **ductus arteriosus** open in utero; by inhibiting its production, indomethacin facilitates the closure of a **patent ductus arteriosus (PDA)** in neonates. *Misoprostol* - **Misoprostol** is a **prostaglandin E1 (PGE1) analog** and is used to induce labor, treat gastric ulcers, and for medical abortions. - It would work to **maintain** rather than close the **ductus arteriosus** if used in a neonate with a heart defect requiring patency. *Dinoprostone* - **Dinoprostone** is a **prostaglandin E2 analog** used for cervical ripening and labor induction. - It is not used for closing a **PDA**; its prostaglandin agonistic action would likely keep the **ductus arteriosus open**. *PGE-2* - **Prostaglandin E2 (PGE2)** is a naturally occurring prostaglandin that helps maintain the patency of the **ductus arteriosus** in the fetus. - Administering **PGE2** would keep the **ductus arteriosus open**, which is the opposite of the desired effect when treating a **PDA**.
Question 1066: Which drug is used to keep the patent ductus arteriosus (PDA) open?
- A. PGE1 (Correct Answer)
- B. PGI2
- C. PGH2
- D. PGF2α
Explanation: ***PGE1*** - **Prostaglandin E1** (**PGE1**, alprostadil) is used to maintain the patency of the **ductus arteriosus** in neonates with certain congenital heart defects [1], [2]. - It acts as a **vasodilator** on the smooth muscle of the ductus, preventing its closure and allowing for adequate blood flow prior to surgical correction [1], [2]. *PGI2* - **Prostaglandin I2** (**PGI2**, prostacyclin) is a potent **vasodilator** and **platelet aggregation inhibitor** [1]. - While it has cardiovascular effects, it is primarily used for conditions like **pulmonary hypertension** and not for maintaining ductal patency [1]. *PGF2̑* - **Prostaglandin F2̑** (**PGF2̑**) is involved in processes such as **uterine contractions** and **bronchoconstriction** [1], [2]. - It does not play a role in maintaining the patency of the ductus arteriosus. *PGH2* - **Prostaglandin H2** (**PGH2**) is an immediate precursor in the synthesis of various other prostaglandins and thromboxanes. - It is not directly administered as a drug to maintain ductal patency but is an intermediate in their synthesis.
Question 1067: Drug of choice for familial hypercholesterolemia?
- A. Nicotinic acid
- B. Lovastatin (Correct Answer)
- C. Cholestyramine
- D. Gemfibrozil
Explanation: ***Lovastatin*** - **Statins** (HMG-CoA reductase inhibitors) are the **first-line therapy** for familial hypercholesterolemia as they effectively lower **LDL cholesterol** levels by inhibiting cholesterol synthesis [1]. - While other agents can be used adjunctively, statins like lovastatin are the cornerstone for managing this genetic condition [2]. *Nicotinic acid* - **Nicotinic acid** (niacin) primarily lowers **triglycerides** and increases **HDL cholesterol**, but it is less potent than statins for reducing LDL-C, especially in familial hypercholesterolemia [1]. - Its use is often limited by significant **side effects** like flushing. *Cholestyramine* - **Cholestyramine** is a **bile acid sequestrant** that binds to bile acids in the intestine, preventing their reabsorption and mildly lowering LDL cholesterol. - It is less effective than statins and often causes **gastrointestinal side effects** such as constipation and bloating. *Gemfibrozil* - **Gemfibrozil** is a **fibrate**, primarily used to lower **triglyceride levels** and increase HDL cholesterol. - It has minimal impact on LDL cholesterol compared to statins and is not the primary treatment for familial hypercholesterolemia [2].
Question 1068: What are the primary mechanisms behind cardiac toxicity associated with Tricyclic antidepressants?
- A. Norepinephrine reuptake inhibition only
- B. Anticholinergic effects on the heart
- C. Both norepinephrine reuptake inhibition and anticholinergic effects on the heart (Correct Answer)
- D. Direct membrane stabilizing effects only
Explanation: ***Both norepinephrine reuptake inhibition and anticholinergic effects on the heart*** - **Tricyclic antidepressants (TCAs)** block the reuptake of **norepinephrine**, which can lead to increased sympathetic tone on the heart and potentially **tachyarrhythmias** or other cardiac complications. - TCAs also have potent **anticholinergic effects**, blocking muscarinic receptors in the heart; this can increase **heart rate** and affect cardiovascular stability. - While **direct membrane stabilizing effects** (sodium channel blockade) are critical for **QRS widening and conduction delays**, the combination of norepinephrine reuptake inhibition and anticholinergic effects accounts for the broader spectrum of **TCA-induced cardiac toxicity** including tachycardia and hemodynamic instability. *Norepinephrine reuptake inhibition only* - While TCAs do inhibit norepinephrine reuptake contributing to tachycardia and increased sympathetic tone, this mechanism alone does not fully explain the breadth of cardiac effects seen with these drugs. - The **anticholinergic effects** play a significant additional role in altering cardiac function. *Anticholinergic effects on the heart* - While TCAs do exert anticholinergic effects that can impact heart rate and cardiovascular function, this mechanism alone fails to account for the additional contributions from **norepinephrine reuptake inhibition** to the overall cardiac toxicity. - The combination of both mechanisms is necessary for a complete understanding of **TCA-induced cardiac effects**. *Direct membrane stabilizing effects only* - This option refers to the **quinidine-like action** of TCAs, which involves blocking myocardial fast sodium channels, leading to a **prolonged QRS interval** and increased risk of **ventricular arrhythmias** and **conduction defects**. - While direct membrane stabilization is the **primary mechanism of TCA-induced conduction abnormalities** (QRS widening, heart blocks), the question asks for mechanisms of broader **cardiac toxicity**, which includes the combined effects of norepinephrine reuptake inhibition and anticholinergic actions on heart rate and hemodynamics.
Question 1069: Nesiritide causes vasodilation through?
- A. ATP
- B. Cyclic adenosine monophosphate (cAMP)
- C. K+ ions
- D. Guanosine 3',5'-cyclic monophosphate (cGMP) (Correct Answer)
Explanation: ***Guanosine 3',5'-cyclic monophosphate (cGMP)*** - **Nesiritide** is a synthetic **B-type natriuretic peptide (BNP)** that acts as a potent vasodilator [2]. - It works by binding to **guanylyl cyclase receptors**, leading to an increase in intracellular **cGMP**, which promotes smooth muscle relaxation [1], [2]. *Cyclic adenosine monophosphate (cAMP)* - While **cAMP** is a crucial second messenger in various cellular processes and can mediate some forms of vasodilation, it is primarily associated with **beta-adrenergic receptor activation**, not the mechanism of action of nesiritide. - Nesiritide's pathway is distinct from those involving **cAMP-mediated** relaxation, which often involves different kinases and protein phosphorylation. *ATP* - **ATP** (adenosine triphosphate) is the primary **energy currency** of the cell and is involved in numerous cellular functions, including muscle contraction and relaxation, but it is not a direct mediator of nesiritide's vasodilatory effects. - Though ATP can be broken down to produce **adenosine**, which has vasodilatory properties, this is not the specific mechanism through which nesiritide causes vasodilation. *K+ ions* - Changes in **potassium ion (K+)** flux across cell membranes are essential for regulating vascular tone, as K+ channel activation can lead to hyperpolarization and relaxation of smooth muscle. - However, **nesiritide's primary mechanism** of action does not involve direct modulation of K+ channels; its vasodilatory effects are mediated by the **cGMP pathway** [2].
Question 1070: Which of the following is NOT a side effect of digitalis?
- A. Nausea and vomiting
- B. Ventricular Bigeminy
- C. Vasodilatation (Correct Answer)
- D. Ventricular tachycardia
Explanation: **Vasodilatation** - **Digitalis**, primarily digoxin, is known for its **positive inotropic effect**, increasing myocardial contractility, and for its **vasoconstrictive properties** at higher doses due to sympathetic activation and direct smooth muscle effects, not vasodilatation. - While it can indirectly improve cardiac output and thus tissue perfusion, its direct vascular effects do not typically include widespread vasodilatation. *Ventricular tachycardia* - **Digitalis toxicity** can lead to various arrhythmias, including **ventricular tachycardia**, which is a potentially life-threatening side effect. - This occurs due to increased automaticity and delayed afterdepolarizations in ventricular myocytes. *Nausea and vomiting* - **Gastrointestinal symptoms** such as **nausea and vomiting** are common early signs of digitalis toxicity. - These effects are thought to be mediated by the drug's action on the chemoreceptor trigger zone in the brainstem. *Ventricular Bigeminy* - **Ventricular bigeminy**, characterized by alternating normal and premature ventricular beats, is another classic manifestation of **digitalis toxicity**. - This arrhythmia results from enhanced automaticity and altered conduction properties in the ventricles.
Practice by Chapter
Antihypertensive Agents
Practice Questions
Drugs for Heart Failure
Practice Questions
Antiarrhythmic Drugs
Practice Questions
Antianginal Agents
Practice Questions
Lipid-Lowering Drugs
Practice Questions
Anticoagulants and Antiplatelet Drugs
Practice Questions
Thrombolytic Agents
Practice Questions
Drugs Used in Pulmonary Hypertension
Practice Questions
Drugs Used in Shock
Practice Questions
Cardiovascular Effects of Non-Cardiovascular Drugs
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free